Pharma Innovation Hub by Sudhanshu

Home
India
Ahmedabad
Pharma Innovation Hub by Sudhanshu

💊 Pharma Knowledge | Drug Science | Innovation
📚 Simplifying Pharmacy Learning
🚀 Industry Insights & Career Growth
👨‍⚕️ Pharma Innovation Hub by Sudhanshu

23/03/2026

From India to the World: How CDSCO and USFDA Define Drug Approvals

For professionals entering Regulatory Affairs (RA), understanding two key regulators is essential: CDSCO and USFDA. These authorities define drug approval pathways, compliance standards, and global market access.

CDSCO (India) 🇮🇳

India’s national drug regulator under the Ministry of Health & Family Welfare. It ensures drugs and medical devices meet standards of safety, quality, and efficacy under the Drugs & Cosmetics Act, 1940.

Key points:
• Portal: SUGAM
• Application: Form 44 – New Drug
• Format: CTD / eCTD
• Review: Subject Expert Committee (SEC)
• Timeline: ~12 months
• Registration validity: 5 years

USFDA (USA) 🇺🇸

The United States Food and Drug Administration is widely regarded as the global benchmark for drug regulation and manufacturing compliance.

Key points:
• Applications: NDA / ANDA / BLA
• Format: eCTD (mandatory)
• Timeline: ~10 months standard review / ~6 months priority review
• Regulations: 21 CFR Parts 210 & 211 (cGMP)
• Oversight: Inspections, Form 483, warning letters, recalls

Why This Matters for RA Careers?

Most Indian pharma companies operate in both domestic and export markets.
• Knowing CDSCO → enables Indian market approvals
• Knowing USFDA → supports global regulatory submissions
• Knowing both → builds a strong global regulatory career

As CDSCO increasingly aligns with international standards and adopts eCTD systems, regulatory professionals with knowledge of both frameworks are becoming highly valuable.

Bottom line:
CDSCO gets your drug approved in India.
USFDA opens the door to global pharmaceutical markets.

19/03/2026

⚙️ Equipment Qualification in Sterile Injectable Manufacturing
In pharmaceutical manufacturing, especially for sterile injectable products, equipment qualification is essential to ensure that manufacturing systems consistently operate according to predefined specifications and comply with GMP requirements.
The equipment qualification lifecycle ensures that systems used for compounding, filtration, filling, sterilization, and packaging perform reliably throughout their operational life.
Key stages include:
✔ URS (User Requirement Specification) – Defines the functional, operational, and regulatory requirements for the equipment.
✔ DQ (Design Qualification) – Ensures that the selected equipment design meets the URS and GMP expectations.
✔ FAT (Factory Acceptance Test) – Verification performed at the manufacturer’s site to confirm that the equipment operates according to design specifications before delivery.
✔ SAT (Site Acceptance Test) – Testing conducted after installation to ensure the equipment is correctly installed and integrated with facility utilities.
✔ IQ (Installation Qualification) – Documents that the equipment installation complies with approved drawings, specifications, and manufacturer recommendations.
✔ OQ (Operational Qualification) – Demonstrates that the equipment operates within defined operational ranges and control parameters.
✔ PQ (Performance Qualification) – Confirms that the equipment consistently performs effectively during routine production conditions.
✔ RQ (Re-Qualification / Periodic Qualification) – Periodic verification performed to ensure the equipment continues to operate in a validated state during its lifecycle.
For sterile injectable facilities, robust equipment qualification supports process consistency, contamination control, and regulatory compliance, ensuring the reliable production of safe and high-quality medicines.

11/03/2026

FIFO vs FEFO – A Small Warehouse Story 📦

Two batches arrive in the warehouse.

Batch A arrives on 1st March with expiry 30 June.
Batch B arrives on 5th March with expiry 30 April.

Now the question is: Which batch should be dispatched first?

🔹 FIFO (First In, First Out)
If we follow FIFO, Batch A will go out first because it arrived earlier.

🔹 FEFO (First Expired, First Out)
If we follow FEFO, Batch B will go out first because it expires earlier.

👉 The difference is simple:
FIFO focuses on arrival date.
FEFO focuses on expiry date.

📊 Where they are commonly used:
FIFO:
Retail, manufacturing materials, general warehouse inventory

FEFO:
Pharmaceuticals, food, dairy, FMCG, chemicals

💡 Why it matters?
Using the right method helps reduce wastage, improve product quality, and maintain efficient inventory control.
In supply chain management, the right rotation strategy can save both cost and product value.

Pharma Innovation Hub by Sudhanshu

08/03/2026

🔹 User Requirement Specification (URS) – The Foundation of Equipment Qualification

Before any pharmaceutical equipment is purchased or installed, the process begins with a User Requirement Specification (URS).

📌 What is URS?
URS is a documented list of requirements that defines what the user expects from equipment, systems, or utilities. It ensures the equipment selected will meet operational, regulatory, and quality requirements.

📌 Why URS is Important?
✔ Clearly defines user and process needs
✔ Ensures compliance with GMP and regulatory guidelines
✔ Provides the basis for DQ, IQ, OQ, and PQ activities
✔ Helps vendors design equipment according to required specifications
✔ Reduces risk of deviations and redesign during qualification

📌 Typical Contents of URS
• Equipment description and intended use
• Capacity and performance requirements
• Utility requirements (power, compressed air, water, etc.)
• Material of construction
• Safety and GMP requirements
• Automation and control requirements
• Documentation requirements

👉 Remember: A well-written URS simplifies the entire equipment qualification and validation lifecycle.
💡 Qualification starts with URS and ends with PQ.

Sudhanshu Jha

07/03/2026

🌍 Navigating the global pharmaceutical landscape requires more than scientific expertise — it demands a clear understanding of regulatory frameworks across regions.

From drug approval to post-marketing pharmacovigilance, major regulatory bodies play a critical role in ensuring quality, safety, and efficacy worldwide.

Here’s a quick overview of key global authorities:

🇺🇸 Food and Drug Administration – Drug approval, safety monitoring, PV regulations.
🇬🇧 Medicines and Healthcare products Regulatory Agency – Regulation, licensing, drug safety.
🇦🇺 Therapeutic Goods Administration – Evaluation, approval, GMP compliance.
🇮🇳 Central Drugs Standard Control Organization – Drug regulation, approvals, pharmacovigilance.
🇨🇦 Health Canada – Drug safety, risk management, market authorization.
🇪🇺 European Medicines Agency – EU drug evaluation, safety oversight, approvals.
🇯🇵 Pharmaceuticals and Medical Devices Agency & Ministry of Health, Labour and Welfare – Approval, safety checks, post-marketing PV
Understanding how these agencies operate is essential for professionals in Regulatory Affairs, Pharmacovigilance, Clinical Research, and Quality Assurance.

Global compliance is not just about meeting requirements — it’s about maintaining patient trust and protecting public health across borders.

06/03/2026

Question: Why we mainly focus on 0.5 µm and 5.0 µm particles in pharma?

Here's the reason:

* 0.5 µm particles
These are small enough to remain airborne for long periods and are often associated with microorganisms or contamination sources. They are critical indicators of cleanroom performance as per ISO 14644 and GMP guidelines.

*5.0 µm particles
These represent larger contamination risks such as dust, skin flakes, and aggregates. They help evaluate filtration efficiency and environmental control.

1. Why not smaller than 0.5 µm?
Very tiny particles are difficult to detect accurately with standard particle counters. They are less likely to carry viable contamination compared to larger particles.

2. Why not larger than 5 µm?
Larger particles settle quickly due to gravity.
HEPA filters effectively remove them from controlled environments.

**Conclusion**:
Monitoring 0.5 µm and 5.0 µm particles provides a practical, regulatory-compliant, and scientifically relevant method to assess cleanroom air quality and contamination control.

Address

Ahmedabad
380001

Website

https://facebook.com/PharmaInnovationHubBySudhanshu

Alerts

Be the first to know and let us send you an email when Pharma Innovation Hub by Sudhanshu posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Want your practice to be the top-listed Clinic in Ahmedabad?